July 2026
The oncology combination therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The global combination antibody therapy market size is estimated to hit around USD 700.59 billion by 2035 increasing from USD 268.17 billion in 2026, with a CAGR of 11.26%.
September 2026
The global continuous renal replacement therapy consumables market size was evaluated at USD 997.83 million in 2026 and is predicted to hit around USD 2,069.01 million by 2035, growing at a CAGR of 8.44%.
September 2026
The global cell and gene therapy market size was calculated at USD 10.44 billion in 2026 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
September 2026
The photothermal therapy patches market size stood at USD 295.83 billion in 2026, with major photothermal therapy patches market companies including Photothermal Therapeutics Inc., NanoHybrids Inc., BioCure Technology Inc.
September 2026
The global oral oncology specialty pharmacy market is driven by rising cancer burden, increasing use of oral anticancer drugs, and expansion of specialty pharmacy services worldwide.
September 2026
The global non-oncology precision medicine market size is calculated at USD 101.25 billion in 2026 and is projected to hit around USD 222.95 billion by 2035 with a CAGR of 9.23%.
September 2026
The global hormone replacement therapy market size is projected to hit around USD 70.63 billion by 2035 from USD 42.02 billion in 2026 with a notable CAGR of 5.95%.
September 2026
The global shock wave therapy market size is calculated at USD 2.57 billion in 2026 and is projected to hit around USD 6.48 billion by 2035 with a CAGR of 10.82%.
September 2026
The global digital twin in oncology market size was evaluated at USD 594.00 million in 2026 and is predicted to hit around USD 7226.90 million by 2035, growing at a CAGR of 32.00%.
September 2026
The global radiotherapy market size is calculated at USD 9.10 billion in 2026 and is projected to hit around USD 15.56 billion by 2035 with a CAGR of 6.16%.
September 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
September 2026
The global interventional oncology market size was evaluated at USD 3.19 billion in 2026 and is predicted to hit around USD 6.73 billion by 2035, growing at a CAGR of 8.63%.
September 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
September 2026
The global cardiac resynchronization therapy market size is projected to hit around USD 18.33 billion by 2035 from USD 9.73 billion in 2026 with a CAGR of 7.31%.
September 2026
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
September 2026
The global lyophilized oncology drug market size is growing as demand increases for stable, long-lasting cancer formulations and advanced freeze-drying technologies.
September 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
September 2026
The global aromatherapy market size surpassed USD 11.10 billion in 2026 and is estimated to reach around USD 23.31 billion by 2035, expanding at a CAGR of 8.61%.
September 2026
The stem cell therapy market size is expected to increase from USD 20.53 billion in 2026 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
September 2026
The global image-guided therapy systems market size is projected to hit around USD 11.22 billion by 2035 from USD 6.84 billion in 2026 with a notable CAGR of 5.66%.
September 2026
The home infusion therapy market size was valued at USD 45.23 billion in 2026 and is projected to hit around USD 90.65 billion by 2035 with a CAGR of 8.04%.
September 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
September 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
September 2026
The plasma derived therapy market size is accounted at USD 25.01 billion in 2026 and is expected to hit around USD 45.29 billion by 2035 with a CAGR of 6.83%.
September 2026
The global T-cell therapy market size is reached at USD 13.99 billion in 2026 and it is expected to hit around USD 196.21 billion by 2035 with a CAGR of 34.27%.
September 2026
The global gene therapy market size was exhibited at USD 13.24 billion in 2026 and is predicted to hit around USD 63.52 billion by 2035 with a solid CAGR of 19.09%.
September 2026
The oncology market size surpassed USD 279.73 billion in 2026 and is expected to hit around USD 732.45 billion by 2035 with a CAGR of 11.31%.
September 2026
The global immunotherapy drugs market size was valued at USD 376.22 billion in 2026 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
September 2026
The global allogeneic cell therapy devices market size is projected to hit around USD 4,565.79 million by 2035 from USD 511.30 million in 2025 with a CAGR of 24.48%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com